製品詳細
Materials Provided
IDComponentsSizeRAS039-C01Pre-coated Anti-SARS-CoV-2 Spike Protein Antibody Microplate1 plateRAS039-C02SARS-CoV-2 Spike Protein10 μgRAS039-C03HRP-Anti-SARS-CoV-2 Spike Protein Antibody20 μgRAS039-C0410xWashing Buffer50 mLRAS039-C05Dilution Buffer50 mLRAS039-C06Substrate Solution12 mLRAS039-C07Stop Solution7 mLProduct Overview
The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.
Application
This kit is developed for detecting SARS-CoV-2 Spike Protein in vaccine samples,which is the low sensitivity version of Cat. No. RAS-A020.The kit can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quality control, and realize accurate quantification of vaccine antigen contents for COVID-19 vaccines of all technological platforms, multivalent vaccines, and VOC-specific boosters.
It is for research use only.
Reconstitution
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
Storage
1. Unopened kit should be stored at 2℃-8℃ upon receiving.
2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.
3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Assay Principles
This assay kit employs a standard sandwich-ELISA format, providing a rapid detection of SARS-CoV-2 Spike Protein. The kit consists of microplate pre-coated with Anti-SARS-CoV-2 Spike protein Antibody, an SARS-CoV-2 Spike Protein as Control, an HPR-Anti-SARS-CoV-2 Spike protein Antibody,and buffers.
Your experiment will include 5 simple steps:
a) All reagents were returned to room temperature (20°C-25°C) before use.
b) Add your sample to the plate, take the SARS-CoV-2 Spike protein as Control sample. The samples and Control sample are diluted by Dilution Buffer.
c) Add a diluted HRP-Anti-SARS-CoV-2 Spike Protein Antibody to the plate. The diluted by Dilution Buffer.
d) Wash the plate and add TMB.
e) Stop the substrate reaction by add diluted acid. Absorbance (OD) is calculate as the absorbance at 450 nm minus the absorbance at 630 nm to remove background prior to statistical analysis. The OD Value reflects the amount of protein bound.
ACRO Quality Management System
お客様はこちらも閲覧
データ表示
Typical Data
Please refer to DS document for the assay protocol.

Immobilized Anti-SARS-CoV-2 Spike Protein Antibody at 2 μg/mL (100 μL/well) can bind SARS-CoV-2 Spike Protein. Detection was performed using HRP-Anti-SARS-CoV-2 Spike Protein Antibody with sensitivity of 20 ng/mL (QC tested).

SARS-CoV-2 Spike Protein ELISA Kit (For Vaccine Development)(Cat. No. RAS-A039) can potently to detect the all SARS-CoV-2 Variants of Concern (VOCs), including Alpha (Cat. No. SPN-C52H6), Beta (Cat. No. SPN-C52Hk), Gamma (Cat. No. SPN-C52Hg) and Delta (Cat. No. SPN-C52He).

SARS-CoV-2 Spike Protein ELISA Kit (For Vaccine Development) (Cat. No. RAS-A039) can potently to detect the all SARS-CoV-2 Variants of Concern (VOCs), including Omicron (Cat. No. SPN-C52Hz).
ユーザーレビュー コメントを投稿

最新の進展
- 英語名:
Coronavirus spike glycoprotein
- カテゴリ:
- 市販の医薬品数:
15 詳細
- 治験医薬品数:
88 詳細
- 最新の開発ステージ:
Approved
メールアドレス
order.jp@acrobiosystems.comお問い合わせ
グローバル:+1 800-810-0816(Toll Free)



















